| Financial Year |
March 31 2023 |
| Monetary Funds |
257,748,463.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
97,817,001.61 |
| Accounts Receivable |
351,219,852.04 |
| Advances to Suppliers |
122,212,960.68 |
| Other Receivables |
52,472,772.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
630,989,250.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,058,379.24 |
| Total Current Assets |
1,746,525,785.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
89,360,290.98 |
| Investment Properties |
22,115,631.02 |
| Fixed Assetes |
939,993,556.07 |
| Under-construction Projects |
32,313,830.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
211,043,812.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,433,991.75 |
| Deferred Income Tax Assets |
39,216,788.82 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,424,539,549.54 |
| Total Assets |
3,171,065,334.77 |
| Short-Term Loans |
224,119,873.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
53,138,480.00 |
| Accounts Payable |
212,909,357.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
93,450,910.22 |
| Taxes Payable |
19,688,576.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,913,684.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,477,721.10 |
| Other Current Liabilities |
6,352,019.43 |
| Sub-Total of Current Liabilities |
704,912,309.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,370,326.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
67,580,225.31 |
| Total Liabilities |
772,492,535.28 |
| Paid-In Capital(Or Share Stock) |
897,604,831.00 |
| Capital Surplus |
437,165,654.10 |
| Surplus Reserve |
124,271,404.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
707,782,916.97 |
| Minority Stockholder's Interest |
193,015,043.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,205,557,755.78 |
| Owner's Equity（Stockholder's Equity） |
2,398,572,799.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,171,065,334.77 |
